Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
InCarda Therapeutics
AddedFeb 15, 2024
UpdatedJul 17, 2026
InCarda Therapeutics

InCarda Therapeutics

Series A

InCarda Therapeutics: A biotech firm specializing in inhaled therapies for acute cardiovascular conditions.

HQ
Newark, CA, US
Founded
2009
Overview
Compare
Fundraising
Employees
Website

InCarda Therapeutics is a biotechnology company focused on transforming cardiovascular treatment through pulmonary delivery. The company's core mission is to develop and commercialize inhaled therapies for acute cardiovascular conditions, with a particular emphasis on treating paroxysmal atrial fibrillation (PAF). Their flagship product is an orally inhaled antiarrhythmic therapy designed to provide rapid relief for patients experiencing symptomatic, acute episodes of PAF.

InCarda Therapeutics has made significant strides in the biopharmaceutical field by pioneering this novel approach to cardiovascular care. The company's innovative inhalation therapy has garnered positive feedback from actual atrial fibrillation patients, highlighting its potential impact on improving patient outcomes.

InCarda Therapeutics - Similar Companies

Cardeas Pharma logo

Cardeas Pharma

BioCardia logo

BioCardia

Respira Therapeutics logo

Respira Therapeutics

Cardurion Pharmaceuticals logo

Cardurion Pharmaceuticals

CardioFocus logo

CardioFocus

cardiofocus.com

HDL Therapeutics logo

HDL Therapeutics

Native Cardio logo

Native Cardio

nativecardio.com

Innerpulse logo

Innerpulse

Cardax logo

Cardax

cardaxpharma.com

Inhalon Biopharma logo

Inhalon Biopharma

inhalon.com

AdrenaCard logo

AdrenaCard

adrenacard.com

Pulmatrix logo

Pulmatrix

pulmatrix.com

CardieX logo

CardieX

cardiex.com

TransCardiac Therapeutics logo

TransCardiac Therapeutics

Vivasc Therapeutics logo

Vivasc Therapeutics

InCarda Therapeutics - Quick Facts

Who are InCarda Therapeutics' competitors?

Companies similar to InCarda Therapeutics include Cardeas Pharma, BioCardia, Respira Therapeutics and Cardurion Pharmaceuticals.

When was InCarda Therapeutics founded?

InCarda Therapeutics was founded in 2009.

Where is InCarda Therapeutics' headquarters located?

InCarda Therapeutics' headquarters is located in Newark, CA, US.

When was InCarda Therapeutics' last funding round?

InCarda Therapeutics' most recent funding round was for $8.5M (USD) in January 2022.

How much has InCarda Therapeutics raised to-date?

As of Jan 14, 2022, InCarda Therapeutics has raised a total of $86.4M (USD).

How many employees does InCarda Therapeutics have?

InCarda Therapeutics has 10 employees as of Feb 4, 2024.

InCarda Therapeutics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Inhaled Therapy
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified